Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
Open Access
- 12 November 2019
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 20 (1) , 1-8
Abstract
Background: Lung cancer is a leading cause of death from cancer worldwide, especially non-small cell lung cancer (NSCLC). The marker of progression in lung adenocarcinoma, the main type of NSCLC, has been rarely studied. Programmed death 1 (PD-1) is an effective drug target for the treatment of NSCLC. Our study aimed to examine the PD-1 role in the disease process. The study of the effect of polymorphisms on the progression of lung adenocarcinoma in the Han population of Northeast China may provide a valuable reference for the research and application of these drugs. Methods: Chi-square test, Wilcoxon rank sum test, and classification efficiency assessment were used to test SNPs of PD-1 in 287 patients and combined with clinical information. Results: We successfully identified biomarkers (rs2227981, rs2227982, and rs3608432) that could distinguish between lung adenocarcinoma patients of early stages and late stages. Multiple clinical indicators showed significant differences among different SNPs and cancer stages. Furthermore, this gene was confirmed to effectively distinguish the stages of lung adenocarcinoma with RNA-seq data in TCGA. Conclusions: Out study indicated that the PD-1 gene and the SNPs on it could be used as markers for distinguishing lung adenocarcinoma staging in the Northeast Han population. Our investigation into the link between PD-1 polymorphisms and lung adenocarcinoma would help to provide guidance for the treatment and prognosis of lung adenocarcinoma.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (61272388, 61702141)
- the Harbin Applied Technology Research and Development Project (2016RQQXJ105)
- the University Student Innovation and Entrepreneurship Training Program in Heilongjiang Province (201610226012)
This publication has 16 references indexed in Scilit:
- Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trialsOncoImmunology, 2018
- Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015The Lancet Neurology, 2017
- PD-1 and cancer: molecular mechanisms and polymorphismsImmunogenetics, 2017
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypesNature Genetics, 2017
- The chi-square testAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2016
- PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese WomenMedicine, 2016
- Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in ChinaAsian Pacific Journal of Cancer Prevention, 2015
- Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in ChineseJournal of Cancer Research and Clinical Oncology, 2015
- Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma2015
- Incorporation of Clustering Effects for the Wilcoxon Rank Sum Test: A Large‐Sample ApproachBiometrics, 2003